Spyre Therapeutics (SYRE) FCF Margin (QoQ) (2015 - 2023)
Spyre Therapeutics (SYRE) FCF Margin (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 648,702.00 |
| Mar 31, 2023 | 189,156.00 |
| Dec 31, 2022 | -213,727.00 |
| Sep 30, 2022 | -535,266.00 |
| Jun 30, 2022 | -137,670.00 |
| Mar 31, 2022 | -140,222.00 |
| Dec 31, 2021 | -38,632.00 |
| Sep 30, 2021 | -15,742.00 |
| Jun 30, 2018 | 11,688.00 |
| Mar 31, 2018 | -8,977.00 |
| Dec 31, 2017 | 18,420.00 |
| Sep 30, 2017 | -18,823.00 |
| Jun 30, 2017 | 17,589.00 |
| Mar 31, 2017 | -22,502.00 |
| Dec 31, 2016 | 15,471.00 |
| Sep 30, 2016 | -16,660.00 |
| Jun 30, 2016 | 12,065.00 |
| Mar 31, 2016 | -40,941.00 |
| Dec 31, 2015 | 30,923.00 |
| Sep 30, 2015 | -25,164.00 |